DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded at Wall Street Zen

Key Points

• DENTSPLY SIRONA has been upgraded by Wall Street Zen from a "hold" rating to a "buy" rating, reflecting a positive shift in analyst sentiment.
• Despite the upgrade, multiple other analysts have issued decreasing target prices for the stock, with consensus indicating a rating of "Hold" and an average target price of $18.64.
• The company reported a quarterly EPS of $0.52, beating estimates, though its revenue decreased by 4.9% compared to the same quarter last year.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued to investors on Friday.

A number of other equities research analysts have also commented on the company. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Friday. Wells Fargo & Company decreased their price objective on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating for the company in a research note on Friday, August 8th. Barrington Research cut their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating on the stock in a research note on Friday, August 8th. Stifel Nicolaus reduced their target price on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a report on Friday, August 8th. Finally, UBS Group decreased their target price on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research report on Friday, August 8th. Two research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $18.64.

DENTSPLY SIRONA Price Performance

Shares of XRAY opened at $12.50 on Friday. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The company's fifty day moving average price is $14.14 and its 200-day moving average price is $14.81. DENTSPLY SIRONA has a 1-year low of $12.14 and a 1-year high of $27.44. The firm has a market capitalization of $2.49 billion, a PE ratio of -2.64, a price-to-earnings-growth ratio of 0.77 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.50 by $0.02. The company had revenue of $936.00 million during the quarter, compared to analysts' expectations of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm's revenue was down 4.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, equities research analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current year.

Institutional Trading of DENTSPLY SIRONA

Several institutional investors have recently bought and sold shares of the business. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of DENTSPLY SIRONA during the 1st quarter worth approximately $25,000. Trust Co. of Toledo NA OH purchased a new position in DENTSPLY SIRONA during the second quarter valued at $27,000. Parkside Financial Bank & Trust grew its position in shares of DENTSPLY SIRONA by 620.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier's stock valued at $27,000 after purchasing an additional 1,477 shares during the period. Brooklyn Investment Group acquired a new stake in shares of DENTSPLY SIRONA in the first quarter valued at about $26,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of DENTSPLY SIRONA during the first quarter worth about $26,000. 95.70% of the stock is owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.